 |
| 2009BioTaiwan |
|
|
 |
| Visitor
Info |
|
|
|
| ShowReport |
|
|
|
|
|
|
| |
|
| |
| |
|
|
|
 |
International Conference on Center of Excellence
for Clinical Research in Asia-Pacific Realm
| |
|
| Date / Time： |
July 23th, 2008
8:45 A.M. – 5:00 P.M. |
| Venue： |
Room 102, Taipei International Convention Center
No.1, 5 Hsin-Yi Rd., Sec 5, Taipei, Taiwan, 11002, R.O.C. |
| Language： |
English |
| Registration Fee： |
Free |
| Advisor： |
Department of Health, The Executive Yuan |
| Organizer： |
Science and Technology Advisory Group of Executive
YuanTaiwan Bio Industry Organization |
| Co-Organizer： |
Center for Drug Evaluation, Taiwan (CDE)
Medical Research, National Taiwan University Hospital
International Research and Pharmaceutical Manufacturers Association (IRPMA) |
| Organizing Committee： |
Dr. Herng-Der Chern, Executive Director, Center for Drug Evaluation
Dr. Wing-Kai Chan, Director, National Clinical Trial and Research Center, NTUH
Dr. Michelle Lin, Secretary General, Taiwan Bio Industry Organization |
| Apply Now |
| |
Conference Agenda |
|
Time |
Topic |
Moderator/Speaker |
8:45–9:15 am |
Registration |
9:15–9:30 am |
Welcome & Opening Remark |
Honoring Guests:
Dr. Tzay-Jinn Chen
Deupty Minister, DOH, Executive Yuan
|
|
【Morning Session】
Moderator: Dr. Tzay-Jinn Chen
Deupty Minister, DOH, Executive Yuan |
|
9:30–10:10 am |
Taiwan as a Center of Excellence in Clinical Research – NTUHNationalClinicalTrial & ResearchCenter as an example |
Dr. Wing-Kai Chan
Director, National Clinical Trial and Research Center, NTUH |
10:10–10:30 am |
Break |
10:30–11:10 am |
NTUH GSK Clinical R&D Center in Taiwan |
Hans Bock, Director, Clinical R&D and Medical Affairs, GSK Asia-Pacific, China and Hong Kong |
|
11:10–11:50 am |
Novartis Clinical R&D Program in Taiwan |
Michael Graeve, Head of International Clinical Research Operation for Asia-Pacific and Japan, Novartis |
11:50–1:45 pm |
Lunch |
【Afternoon Session】
Moderator: Dr. Heng-Der Chern
Executive Director, Center for Drug Evaluation (CDE) |
|
1:45–2:20 pm |
Competitiveness of Regulatory Infrastructure for Clinical Research in Taiwan |
Dr. Herng-Der Chern
Executive Director, Center for Drug Evaluation (CDE) |
|
2:20–2:50 pm |
ClinicalTrialCenter in NationalCheng-KungUniversityHospital-an establishing new oncology drug development platform in Taiwan |
Dr. Li-Tzong Chen
Deputy Director, National Health Research Institute, National Institute of Cancer Research Professor of Internal Medicine, National Cheng-Kung University Medical College |
2:50–3:15 pm |
Break |
3:15–3:45 pm |
Taiwan as a Center of Excellence for Clinical Research - an industry perspective |
Dr. Albert Liou
Corporate Vice President & General Manager, PAREXEL APEX International Co., Ltd. |
|
3:45–4:15 pm |
Topic (to be confirmed) |
Mr. David Hsu
Project Manager, ICON |
4:15–5:00 pm |
Discussion |
|
|
| |
| Apply Now |
|
| |
| |
| |
| |
| |
|
| |
|
|
|
